CD44 as a tumor biomarker and therapeutic targetHanxiao Xu, Aiguo Liu|Experimental Hematology and Oncology|2020Cited by 405
CD44 correlates with clinicopathological characteristics and is upregulated by EGFR in breast cancerHanxiao Xu, Kongming Wu|International Journal of Oncology|2016Cited by 82